Product Features
• FDA Approved
• SAMHSA Cut-off Levels
• Administrator Activated
• Results in Minutes
Product Links
The One Step Single and Multi-Drug Screen Test Card is a lateral flow chromatographic immunoassay for the qualitative detection of multiple drugs and drug metabolites in urine at the cut-off concentrations listed below. The test utilizes monoclonal antibodies to selectively detect elevated levels of specific drugs in urine.
Dip test cards come in single panel, 2-panel, 3-panel, 4-panel, 5-panel, 6-panel, 8-panel, 9-panel, 10-panel, and 12-panel configurations.
Available Configurations
DMT-114
MTD Methadone Dip Card
25/BOX
insert
DOA-184-271T-OBW68B
8-Panel Test Card - ZERO TOLERANCE PANEL (COC150, AMP300, mAMP500, THC50, MOP, OXY, PPX, PCP)
25/BOX
DOA-1124-011T-OBW68B
12-Panel Test Card - CONSTRUCTION PANEL (COC, AMP, mAMP, THC, MTD, MDMA, OPI, OXY, PPX, PCP, BAR, BZO)
25/BOX
DUD-154-201
5-Panel Test Card w/SVT (COC, AMP, mAMP, THC, OPI) + (OX, S.G., pH, NIT, GLUT, CRE)
25/BOX
DUD-164-141
6-Panel Test Card w/SVT (COC, AMP, mAMP, THC, OPI, BZO) + (OX, S.G., pH, NIT, GLUT, CRE)
25/BOX
DUD-1104-051
10-Panel Test Card w/SVT (COC, AMP, mAMP, THC, MTD, OPI, PCP, BAR, BZO, TCA) + (OX, S.G., pH, NIT, GLUT, CRE)
25/BOX
Cut-off Levels
AMP
AMPHETAMINE
1,000
ng/mL
BAR
BARBITURATES
300
ng/mL
BZO
BENZODIAZEPINES
300
ng/mL
BUP
BUPRENORPHINE
10
ng/mL
COC
COCAINE
300
ng/mL
THC
MARIJUANA
50
ng/mL
MTD
METHADONE
300
ng/mL
mAMP
METHAMPHETAMINE
1,000
ng/mL
MDMA
METHYLENEDIOXYMETHAMPHETAMINE
500
ng/mL
MOP
MORPHINE (OPIATE 300)
300
ng/mL
OPI
OPIATES
2,000
ng/mL
OXY
OXYCODONE
100
ng/mL
PCP
PHENCYCLIDINE
25
ng/mL
PPX
PROPOXYPHENE
300
ng/mL
TCA
TRICYCLIC ANTIDEPRESSANTS
1,000
ng/mL
This assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are indicated.